An Open Label Study in Adults With Atopic Dermatitis to Assess Variability in Immune Response to Fluzone Intradermal Vaccine.

Trial Profile

An Open Label Study in Adults With Atopic Dermatitis to Assess Variability in Immune Response to Fluzone Intradermal Vaccine.

Completed
Phase of Trial: Phase 0

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top